Abstract: The invention relates to antibodies that bind to antigens, such as antigens associated with hyperproliferating cells, and methods of treating hyperproliferative disorders. The invention antibodies are useful for treating hyperproliferative disorders, such as neoplasia.
Type:
Grant
Filed:
September 25, 2008
Date of Patent:
November 9, 2010
Assignee:
Shantha West, Inc.
Inventors:
Subhra Chakrabarti, Sonjoy Mukerjee, Mark C. Glassy
Abstract: The invention relates to antibodies that bind to antigens, such as antigens associated with hyperproliferating cells, and methods of treating hyperproliferative disorders. The invention antibodies are useful for treating hyperproliferative disorders, such as neoplasia.
Type:
Grant
Filed:
December 6, 2006
Date of Patent:
November 4, 2008
Assignee:
Shantha West, Inc.
Inventors:
Subhra Chakrabarti, Sonjoy Mukerjee, Mark C. Glassy
Abstract: The antigen recognized by the antibody produced by a deposited cell line (ATCC accession no. PTA 5411) has been shown to be a fragment of vimentin. This vimentin fragment will be useful in therapy of and screening for cell proliferative disorders such as cancer.
Abstract: The invention relates to antibodies that bind to antigens, such as antigens associated with hyperproliferating cells, and methods of treating hyperproliferative disorders. The invention antibodies are useful for treating hyperproliferative disorders, such as neoplasia.
Type:
Grant
Filed:
September 11, 2003
Date of Patent:
July 3, 2007
Assignee:
Shantha West, Inc.
Inventors:
Subhra Chakrabarti, Sonjoy Mukerjee, Mark C. Glassy
Abstract: The invention relates to antibodies that bind to antigens, such as antigens associated with hyperproliferating cells, and methods of treating hyperproliferative disorders. The invention antibodies are useful for treating hyperproliferative disorders, such as neoplasia.
Type:
Application
Filed:
December 6, 2006
Publication date:
April 26, 2007
Applicant:
SHANTHA WEST, INC.
Inventors:
Subhra Chakrabarti, Sonjoy Mukerjee, Mark Glassy